decad
ago
centenarian
use
appear
mainli
fairi
stori
nowaday
centenarian
japan
soseki
natsum
japanes
writer
london
mean
life
span
male
popul
england
year
old
japan
year
old
mani
countri
mean
life
span
increas
steadili
year
second
world
war
ie
elong
life
span
year
japan
pronounc
elong
life
span
attribut
rapid
progress
medicin
includ
antibiot
suffici
food
suppli
includ
protein
report
healthi
life
span
gener
year
shorter
mean
life
span
mean
mani
elderli
peopl
suffer
diseas
sever
year
death
well
known
incid
cancer
cardiovascular
diseas
neurovascular
diseas
infect
increas
age
autopsi
examin
reveal
largest
caus
death
elderli
infect
bronchopneumonia
urinari
tract
infect
tabl
mac
gee
hirokawa
hirokawa
et
al
regard
infect
pawelec
et
al
suggest
chronic
antigen
stimul
could
lead
increas
preval
senesc
dysfunct
cell
therefor
contribut
gener
alter
immun
system
therefor
restor
immunolog
function
would
quit
help
elderli
prevent
infect
also
maintain
intern
environ
time
exposur
stress
word
immunolog
restor
expect
effect
improv
qol
elderli
immunolog
restor
requir
two
step
first
assess
immunolog
paramet
function
determin
extent
agerel
declin
immun
function
individu
end
level
immunolog
vigor
express
simpl
numer
use
second
select
adequ
method
restor
immunolog
function
check
effect
select
immunolog
restor
measur
method
mention
effect
immunolog
restor
differ
base
individu
method
restor
thu
chapter
deal
follow
quantit
measur
method
assess
immunolog
level
individu
caus
immunolog
suppress
possibl
method
immunolog
restor
elderli
peopl
immun
system
compris
variou
function
consist
mani
type
cell
perform
variou
function
difficult
select
immunolog
paramet
suitabl
assess
whole
level
immun
function
healthi
peopl
patient
suffer
variou
diseas
function
viewpoint
exist
paramet
cellmedi
immun
humor
immun
cytokin
product
prolif
activ
cell
b
cell
antigen
present
dendrit
cell
cell
compris
immun
system
cell
subpopul
b
cell
subpopul
nk
cell
nkt
cell
macrophag
dendrit
cell
none
may
exclud
assess
immunolog
level
whole
anoth
import
aspect
determin
immun
cell
paramet
play
key
role
agerel
declin
immun
function
studi
immunolog
aspect
age
mani
year
confirm
immun
function
suscept
age
diseas
stress
past
year
mani
studi
includ
shown
agerel
declin
mainli
occur
celldepend
immun
function
makinodan
kay
hirokawa
linton
dorshkind
hirokawa
et
al
fulop
et
al
nikolichzugich
innat
immun
consider
function
phenotyp
alter
age
report
hazeldin
lord
howev
agerel
alter
start
thymic
involut
dramat
focus
paramet
relat
celldepend
function
report
agerel
chang
celldepend
immun
system
observ
decreas
cell
number
chang
cell
subpopul
qualit
chang
cell
declin
prolif
capac
fig
therefor
number
whole
cell
subpopul
prolif
activ
cell
use
paramet
assess
extent
agerel
declin
immun
function
henc
perform
flow
cytometr
analysi
eight
paramet
reflect
cell
subpopul
number
cell
cell
number
cell
number
cell
ratio
cell
cell
ratio
number
cell
cell
cell
number
memori
cell
cell
ratio
cell
memori
cell
nm
ratio
prolif
activ
cell
measur
nonspecif
stimul
cell
monoclon
antibodi
defin
new
indic
cell
prolifer
index
tcpi
use
number
prolif
activ
cell
describ
later
addit
cell
number
b
cell
nk
cell
includ
assess
sinc
cell
import
counterpart
immun
function
eight
immun
paramet
assess
extent
agerel
declin
immunolog
function
hereaft
refer
score
immunolog
vigor
siv
individu
shown
fig
sinc
difficult
imagin
immunolog
level
individu
mere
look
valu
eight
paramet
tri
express
immunolog
level
individu
plain
style
valu
immunolog
paramet
fall
within
rang
specifi
databas
paramet
score
three
grade
base
valu
particular
valu
rang
cumul
frequenc
less
valu
observ
healthi
subject
score
indic
low
immun
level
score
indic
moder
immun
level
higher
score
indic
suffici
high
immun
level
sinc
higher
score
ratio
frequent
observ
old
peopl
patient
suffer
diseas
valu
cumul
frequenc
score
higher
score
databas
obtain
approxim
normal
healthi
popul
rang
age
year
immunolog
level
individu
obtain
summat
score
valu
classifi
grade
ie
immunolog
score
allot
iiv
warn
zone
shown
fig
cytokin
product
anoth
import
aspect
immunolog
function
among
mani
cytokin
inform
balanc
help
understand
health
diseas
condit
therefor
employ
three
cytokin
group
group
employ
mani
number
immun
paramet
assess
siv
exampl
siv
use
immun
paramet
name
valu
classifi
five
grade
accord
total
score
v
suffici
high
iv
safeti
zone
iii
observ
zone
ii
warn
zone
critic
zone
tabl
observ
zone
indic
level
siv
averag
need
attent
move
safeti
zone
warn
zone
indic
level
siv
suffici
maintain
health
consider
effort
requir
increas
level
siv
critic
zone
indic
suscept
infect
high
individu
need
admit
asept
isol
defin
new
paramet
cell
prolifer
index
tcpi
calcul
use
number
prolifer
activ
cell
number
cell
essenti
mainten
immun
function
addit
cell
prolifer
essenti
function
cell
immun
includ
process
antigen
recognit
sequenti
divis
cell
four
type
number
prolif
capac
cell
paramet
suffici
number
suffici
prolif
capac
insuffici
number
insuffici
prolif
capac
suffici
insuffici
therefor
arriv
conclus
need
new
paramet
reflect
number
prolif
capac
cell
new
paramet
tcpi
calcul
follow
equationdocumentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
mathrm
tcpi
left
mathrm
mathrm
cell
mathrm
prolifer
mathrm
activ
right
time
left
mathrm
mathrm
cell
mathrm
number
mathrm
per
upmu
mathrm
l
end
document
tcpitcel
prolifer
figur
indic
distribut
tcpi
accord
age
although
wide
individu
variat
agerel
declin
tcpi
obviou
follow
equat
obtaineddocumentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
mathrm
tcpi
left
mathrm
age
right
end
document
word
determin
age
individu
valu
tcpi
use
follow
equat
sinc
age
calcul
number
cell
prolif
activ
age
obtain
equat
hereaft
refer
immunolog
age
ia
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
mathrm
ia
left
mathrm
tcpi
right
end
document
figur
indic
relat
number
cell
age
wide
individu
variat
revers
relationship
number
cell
age
followingdocumentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
left
mathrm
number
mathrm
mathrm
cd
mathrm
cd
mathrm
mathrm
cell
right
mathrm
age
right
left
mathrm
r
end
document
number
name
determin
age
individu
number
cell
use
equat
call
calcul
valu
lymphocyt
age
high
correl
observ
number
cell
tcpi
shown
fig
immunolog
age
lymphocyt
age
almost
compar
may
differ
individu
case
differ
mainli
caus
disproportion
balanc
cell
cell
immunolog
vigor
healthi
peopl
cancer
patient
assess
use
method
mention
fig
agerel
declin
observ
appar
healthi
popul
howev
wide
individu
variat
level
rang
decad
decad
indic
individu
variat
greater
differ
young
old
peopl
observ
cancer
patient
found
distribut
valu
appar
differ
healthi
peopl
agerel
declin
cancer
patient
much
steeper
healthi
peopl
howev
appar
level
cancer
patient
show
wide
rang
individu
variat
although
valu
lower
compar
healthi
peopl
hirokawa
et
al
b
base
grade
differ
healthi
peopl
cancer
patient
much
obviou
fig
healthi
peopl
belong
grade
iv
iii
cancer
patient
belong
grade
iii
ii
indic
immunolog
defici
state
seriou
cancer
patient
thu
consider
attent
given
immunolog
state
cancer
patient
treatment
hirokawa
et
al
figur
show
radar
graph
two
exampl
case
show
eight
immunolog
paramet
siv
score
immunolog
vigor
immunolog
grade
immunolog
age
lymphocyt
age
figur
show
immun
statu
individu
understood
presum
wide
individu
variat
immunolog
vigor
immunolog
function
changeabl
variabl
caus
ie
age
stress
diseas
life
style
food
genet
background
etc
age
unavoid
caus
immunolog
declin
howev
rate
immunolog
declin
age
might
acceler
deceler
surround
environment
factor
control
appropri
intervent
instanc
calor
restrict
extend
life
span
anim
model
enhanc
immunolog
function
old
anim
heilbronn
ravussin
utsuyama
et
al
stress
major
caus
immunolog
declin
forc
disturb
homeostasi
stressor
word
stress
life
life
stress
chrouso
et
al
variou
diseas
includ
minor
one
also
factor
suppress
immunolog
function
incid
cancer
known
increas
advanc
age
partli
caus
decreas
immun
surveil
dunn
et
al
fact
patient
colon
cancer
low
level
siv
hirokawa
et
al
obviou
siv
gener
recov
certain
interv
remov
cancer
lesion
thu
like
presenc
cancer
suppress
immunolog
function
individu
also
well
known
diabet
mellitu
suppress
immunolog
function
variou
therapi
mani
kind
diseas
downregul
immunolog
function
one
exampl
surgic
oper
chemotherapi
cancer
steroid
therapi
autoimmun
diseas
suppress
immun
function
daili
life
varieti
stress
downregul
immun
function
fact
stress
major
caus
immunolog
suppress
life
stress
origin
commun
problem
home
offic
school
diseas
injuri
treatment
diseas
natur
disast
two
solut
stress
avoid
stress
b
allevi
effect
stressavoid
stressneedless
say
best
avoid
stress
possibl
unfortun
howev
stress
unavoid
worthwhil
reconsid
caus
stress
analyz
whether
avoidableallevi
stressit
interest
note
level
stress
seriou
effect
peopl
other
mean
magnitud
stress
depend
respons
individu
instanc
academ
examin
would
seriou
student
studi
beforehand
would
studi
sing
run
chatter
friend
moodalt
activ
sleep
possibl
anoth
good
activ
good
way
allevi
stress
devot
time
hobbi
respect
studi
effect
music
human
found
play
drum
group
could
enhanc
nk
activ
wachi
et
al
koyama
et
al
habit
indic
improp
life
style
poor
sleep
overwork
smoke
excess
drink
irregular
meal
deviat
food
habit
insuffici
physic
exercis
interview
young
peopl
show
lower
level
siv
improp
work
habit
nutrit
import
factor
immunolog
restor
last
year
mean
life
span
japanes
peopl
extend
year
rapid
increas
life
span
partli
due
improv
food
intak
especi
protein
today
peopl
worri
metabol
syndrom
make
effort
eat
much
much
anyth
harm
year
ago
macay
et
al
report
elong
life
span
rat
calor
restrict
mani
studi
sinc
shown
calor
restrict
effect
sever
count
ie
elong
lifespan
enhanc
immunolog
function
allevi
autoimmun
diseas
one
argument
food
restrict
calor
restrict
appear
effect
anim
rear
artifici
environ
laboratori
anim
coloni
utsuyama
et
al
laboratori
anim
fed
highli
nutrit
chow
without
given
enough
space
tool
physic
exercis
word
immunolog
improv
food
restrict
might
seen
overf
anim
perform
physic
exercis
order
test
conjectur
employ
automat
feed
devic
electr
interlock
run
wheel
devic
provid
constant
run
exercis
anim
fed
determin
amount
diet
rat
ichikawa
et
al
rat
individu
rear
automat
feed
devic
month
month
age
age
month
rat
sacrif
examin
variou
indic
includ
immunolog
function
bodi
weight
almost
rat
fed
ad
libitum
given
restrict
diet
bodi
weight
significantli
greater
rat
given
restrict
diet
bodi
weight
given
restrict
diet
togeth
physic
exercis
almost
rat
given
restrict
diet
without
physic
exercis
high
prolif
respons
cell
observ
rat
given
restrict
diet
togeth
physic
exercis
fig
meanwhil
studi
ongo
observ
effect
calor
restrict
variou
physiolog
paramet
monkey
roth
et
al
report
provid
evid
cr
delay
immun
senesc
nonhuman
primat
potenti
contribut
extend
lifespan
reduc
suscept
infecti
diseas
messaoudi
et
al
human
effect
cr
life
extens
actual
present
estim
cr
extend
life
year
extens
much
smaller
achiev
medic
public
health
intervent
known
extend
life
year
develop
countri
twentieth
centuri
everitt
le
couteur
commonli
believ
oxid
stress
caus
reactiv
oxygen
speci
free
radic
major
caus
age
phenomena
variou
diseas
harman
ame
et
al
wakikawa
et
al
declin
immun
function
one
major
age
phenomena
constitut
background
variou
diseas
occur
elderli
peopl
hirokawa
et
al
mani
investig
assum
oxid
stress
play
import
role
progress
immunolog
declin
cours
age
martin
et
al
meydani
et
al
thu
expect
enzym
substanc
compet
oxid
stress
candid
antiag
medicin
antioxid
enzym
present
bodi
eg
sod
catalas
possibl
enhanc
product
antioxid
enzym
appropri
physic
exercis
addit
mani
kind
supplement
commerci
avail
antioxid
chemic
although
effect
prove
scientif
flavonoid
polyphenol
repres
antioxid
contain
mani
kind
veget
fruit
food
extract
enrich
flavonoid
polyphenol
commerci
avail
supplement
effect
supplement
requir
studi
vitamin
e
work
antioxid
research
group
found
conflict
effect
experi
use
age
mice
confirm
enhanc
immun
function
young
old
mice
wakikawa
et
al
fig
report
indic
supplement
effect
humor
immun
respons
modul
young
middleag
elderli
women
park
et
al
hand
meydani
group
report
posit
effect
human
anim
experi
meydani
et
al
marko
et
al
report
suggest
effect
supplement
uniform
differ
individu
genet
background
effect
antioxid
relat
supplement
usual
vari
individu
therefor
immunolog
assess
perform
object
manner
determin
siv
alway
necessari
verifi
effect
chemic
supplement
immun
system
examin
effect
supplement
human
use
quantit
assess
immunolog
function
mention
georg
et
al
oda
et
al
suzuki
et
al
vaccin
use
protect
children
suscept
variou
infecti
diseas
due
immatur
immun
system
effect
could
expect
elderli
peopl
impair
immun
function
howev
vaccin
old
peopl
may
work
due
depress
immun
function
thu
vaccin
start
latest
age
individu
still
suffici
capac
respond
pathogen
organ
altern
attempt
made
enhanc
stimul
depress
immun
capac
elderli
peopl
time
vaccin
addit
gender
differ
influenc
vaccin
uptak
respons
outcom
older
age
individu
fink
klein
suscept
old
mice
infect
clearli
observ
experiment
infect
influenza
viru
old
mice
die
infect
lesser
dose
influenza
viru
old
mice
surviv
exposur
low
dose
show
strong
immun
viru
becam
resist
second
infect
high
dose
influenza
viru
hirokawa
utsuyama
data
suggest
vaccin
use
protect
elderli
peopl
variou
kind
infect
human
vaccin
pneumococcu
influenza
viru
alreadi
clinic
conduct
elderli
peopl
state
earlier
section
individu
variat
even
elderli
peopl
higher
immun
function
respond
vaccin
show
suffici
immun
bacteria
viru
problem
find
way
enhanc
immunolog
function
elderli
peopl
lower
immun
function
effect
respond
vaccin
anoth
point
consid
rout
vaccin
sinc
nose
mouth
major
entri
respiratori
infect
mucos
immun
import
use
mous
model
found
rout
vaccin
import
vaccin
intranas
rout
provid
high
level
iga
product
nasal
mucosa
intraven
intraperiton
rout
tabl
asanuma
et
al
recent
intranas
vaccin
perform
human
adult
use
inactiv
whole
influenza
viru
ainai
et
al
group
japanes
herbal
medicin
call
kampohozai
use
improv
physic
condit
patient
suffer
variou
diseas
utsuyama
et
al
among
kind
kampohozai
hochuekkito
drug
use
recov
immun
function
report
use
heal
infect
yamaoka
et
al
mori
et
al
oncostaticsinduc
leukopenia
kaneko
et
al
juzentaihoto
use
recoveri
immun
function
abe
et
al
also
enhanc
antitumor
effect
saiki
et
al
onishi
et
al
utsuyama
et
al
test
effect
japanes
herbal
medicin
young
age
mice
data
indic
hochuekkito
effect
restor
impair
immun
function
age
mice
term
number
cell
nk
cell
antisrbc
antibodi
respons
howev
effect
enhanc
immun
function
young
mice
fig
juzentaihoto
also
effect
increas
number
cell
nk
cell
age
mice
although
signific
increas
observ
young
mice
function
howev
nk
activ
increas
young
old
mice
signific
decreas
also
observ
number
metastat
pulmonari
coloni
melanoma
cell
young
old
mice
treat
juzentaihoto
week
fig
nowaday
sever
paper
report
effect
japanes
herbal
medicin
one
show
juzentaihoto
increas
prolong
antibodi
product
influenza
vaccin
elderli
peopl
saiki
et
al
result
suggest
japanes
herbal
medicin
use
restor
impair
immun
function
old
mice
could
recommend
elderli
peopl
immunolog
problem
perform
preliminari
clinic
trial
observ
effect
immunolog
function
human
result
show
effect
vari
individu
approxim
half
peopl
given
show
posit
effect
anoth
half
show
effect
figur
show
exampl
case
posit
effect
therefor
case
also
assess
immunolog
paramet
necessari
verifi
effect
herbal
medicin
immunolog
restor
gonadectomi
hypertrophi
thymu
observ
age
mice
rang
age
month
mice
gonadectom
month
sacrific
magnitud
thymic
regener
pronounc
male
femal
fig
howev
enhanc
antisrbc
antibodi
respons
observ
femal
male
regardless
age
gonadectomi
brought
thymic
hypertrophi
also
increas
cell
b
cell
spleen
increas
cell
subpopul
proport
femal
mice
disproport
male
disproport
increas
cell
subpopul
could
account
failur
enhanc
antisrbc
antibodi
respons
male
mice
utsuyama
hirokawa
gonadectomi
also
result
thymic
hypertrophi
male
femal
young
wistar
rat
previous
hypophysectom
utsuyama
hirokawa
elderli
male
undergo
orchidectomi
prostat
carcinoma
demonstr
increas
circul
cell
number
particularli
naiv
trec
cell
chemic
castrat
administr
lhrh
antagonist
also
effect
activ
thymic
regener
mice
human
sutherland
et
al
femal
hormon
replac
therapi
hrt
estrogen
prescrib
postmenopaus
women
prevent
varieti
medic
condit
includ
osteoporosi
cardiovascular
diseas
stroke
alzheim
diseas
yet
hrt
often
associ
alter
immun
paramet
fahlman
et
al
stopinskagluszak
et
al
hrt
go
reconsid
sinc
estrogen
close
relat
carcinogenesi
mammari
cancer
growth
hormon
play
key
role
develop
age
thymu
celldepend
immun
system
hirokawa
et
al
activ
immun
function
occur
male
femal
administr
ghrh
khorram
et
al
koo
et
al
sinc
elderli
peopl
frequent
occult
carcinoma
thyroid
prostat
organ
need
consid
possibl
increas
level
growth
hormon
may
stimul
prolifer
tumor
cell
give
rise
clinic
manifest
occult
carcinoma
peryy
et
al
anoth
import
inform
kind
tradeoff
situat
thymu
gh
hirokawa
et
al
gh
necessari
develop
thymu
depend
immun
system
later
life
gh
defici
favor
long
life
span
decreas
occurr
cancer
diabet
mellitu
cyclophosphamid
cy
antitumor
drug
commonli
use
chemotherapi
human
cancer
also
known
potent
immunosuppress
drug
human
experiment
anim
interest
cy
influenc
impair
immunolog
function
age
mice
ishiyama
et
al
age
mice
treat
low
dose
cy
show
significantli
enhanc
immun
capac
term
cell
prolifer
celldepend
antibodi
respons
fig
mice
total
cell
number
cell
increas
thymu
spleen
compar
nontreat
mice
treatment
low
dose
cy
induc
apoptosi
thymocyt
atroph
thymu
age
mice
follow
increas
prolifer
thymocyt
increas
thymocyt
splenic
cell
treatment
high
dose
cy
also
induc
apoptosi
thymu
suppress
prolif
capac
therebi
lead
enhanc
immun
capac
cy
young
mice
howev
suppress
immun
capac
regardless
dose
thymocyt
splenic
cell
young
mice
suscept
cy
age
mice
decreas
number
treatment
even
low
dose
cy
human
applic
berd
et
al
report
low
dose
cy
enhanc
cellmedi
humor
immun
patient
advanc
cancer
examin
siv
patient
colorect
cancer
chemotherapi
found
eight
patient
show
trend
increas
siv
week
start
chemotherapi
fig
anim
experi
level
immun
function
age
mice
restor
level
approach
young
adult
mice
graft
newborn
thymu
bonemarrow
young
donor
hirokawa
utsuyama
result
suggest
intrins
cellular
chang
immun
system
respons
immun
defici
age
environment
structur
tissu
chang
includ
connect
tissu
humor
factor
thymu
graft
howev
thymic
stromal
tissu
rather
thymocyt
import
restor
celldepend
immun
system
human
applic
transplant
bonemarrow
cell
becom
easier
almost
imposs
find
donor
young
thymus
donor
need
mhc
type
recipi
thymu
transplant
may
perform
autolog
thymu
partial
remov
young
age
store
liquid
nitrogen
meanwhil
research
accumul
data
molecul
thymic
epitheli
cell
essenti
cell
differenti
zunigapfuck
utsuyama
et
al
accordingli
near
futur
may
possibl
reconstruct
artifici
thymu
use
easili
avail
cell
individu
test
effect
infus
activ
cell
use
young
old
mice
hirokawa
et
al
studi
employ
congen
combin
mice
young
old
donor
mice
young
old
recipi
determin
mani
activ
cell
surviv
recipi
mice
sacrif
day
day
infus
activ
cell
use
immunolog
assess
infus
activ
cell
splenic
lymphocyt
expand
presenc
immobil
monoclon
antibodi
lymphocyt
activ
way
compos
mostli
cell
approxim
cell
cell
activ
cell
prepar
old
mice
donor
contain
mani
cell
although
cell
smaller
number
cell
express
phenotyp
cell
infus
activ
cell
absolut
number
cell
significantli
increas
spleen
recipi
mice
especi
old
mice
peripher
blood
spleen
donortyp
cell
significantli
numer
old
recipi
young
one
addit
number
donortyp
cell
surviv
significantli
high
spleen
peripher
blood
young
old
recipi
magnitud
antibodi
format
srbc
chang
significantli
young
recipi
half
old
recipi
howev
show
signific
enhanc
antibodi
format
import
note
enhanc
antibodi
format
observ
old
recipi
infus
activ
cell
either
young
old
donor
cell
peripher
blood
healthi
peopl
easili
expand
vitro
presenc
immobil
monoclon
antibodi
moab
infus
activ
autolog
cell
wide
use
cancer
patient
form
immunotherapi
rosenberg
without
signific
impact
cancer
treatment
mani
case
howev
expect
activ
cell
expand
vitro
nonspecif
manner
may
improv
immun
defici
statu
elderli
peopl
cancer
patient
cell
expand
nonspecif
manner
may
contain
harm
cell
exhibit
autoimmun
activ
respect
recent
paper
report
infus
activ
autolog
cell
enhanc
promot
autoimmun
activ
yamaguchi
et
al
next
step
examin
cancer
patient
advanc
stage
patient
tongu
cancer
case
esophag
cancer
case
lung
cancer
case
gastric
pancreat
cancer
case
colon
cancer
case
appendic
cancer
case
ovarian
cancer
case
patient
advanc
stage
cancer
multipl
metastas
underw
infus
autolog
activ
cell
socal
lak
cell
activ
autolog
cell
prepar
studi
compris
cell
ratio
approxim
proport
nk
cell
less
activ
cell
number
cell
per
infus
approxim
infus
repeat
time
week
variou
paramet
examin
infus
activ
autolog
cell
pronounc
improv
observ
cell
prolifer
index
tcpi
improv
tcpi
observ
case
infus
averag
tcpi
increas
although
definit
lower
healthi
control
obviou
whether
infus
activ
autolog
cell
effect
reduc
tumor
size
patient
reveal
gener
experienc
improv
health
statu
infus
hirokawa
et
al
figur
show
eight
immunolog
paramet
infus
activ
autolog
cell
cancer
patient
immunolog
paramet
examin
improv
infus
except
ratio
cell
subpopul
obviou
increas
observ
number
cell
tcpi
improv
immunolog
function
expect
cancer
patient
whose
cell
expans
vitro
less
effici
thu
consid
sourc
cell
good
techniqu
obtain
cell
patient
suffer
cancer
individu
healthi
condit
purpos
need
obtain
peripher
blood
lymphocyt
healthi
peopl
lymphocyt
kept
frozen
state
process
name
cellbank
system
establish
cell
bank
way
proper
assess
level
immunolog
function
import
mainten
healthi
condit
prognosi
diseas
purpos
develop
immunolog
score
system
use
nearli
ten
immunolog
paramet
word
instead
list
sever
valu
immunolog
paramet
simpl
numer
immunolog
score
grade
tell
us
level
immunolog
function
whole
cell
prolifer
index
tcpi
new
immunolog
paramet
calcul
number
cell
cellprolif
activ
tcpi
neg
correl
chronolog
age
possibl
obtain
immunolog
age
use
correl
formula
number
cell
also
neg
correl
chronolog
age
lymphocyt
age
calcul
use
correl
formula
number
cell
chronolog
age
familiar
immun
system
rel
easi
guess
level
immunolog
vigor
immunolog
age
lymphocyt
age
immunolog
age
well
correl
lymphocyt
age
individu
level
differ
observ
assess
method
immunolog
level
mention
chapter
use
judgment
health
level
mani
method
restor
depress
immunolog
level
elderli
peopl
case
immunolog
assess
method
describ
conveni
judgment
immunolog
restor
immunolog
level
mostli
declin
cancer
patient
therapi
variou
method
thu
cancer
patient
need
assess
immunolog
level
immunolog
restor
addit
method
use
check
effect
newli
develop
drug
supplement
immunolog
function
futur
direct
includ
function
regulatori
aspect
immun
system
assess
method
ie
number
regulatori
cell
treg
activ
cytokin
product
cultur
cell
level
kill
protein
nk
cell
cell
